north40000 

My AMRN Pitch: "https://tinyurl.com/y9shcxeh
https://tinyurl.com/y5atlfgy
https://tinyurl.com/y7qp2yy3
https://www.acc.org/beyondldl
https://www.amarincorp.com/
https://tinyurl.com/yaajygmp
https://tinyurl.com/y76z86ga
http://tinyurl.com/jnx6w6p"

My GILD Pitch: "Our basis is split-adjusted $0.758/share, acquired 06-1996.GILD's Focus is on treatments for HIV, HCV, HBV, Oncology, future acquisitions. http://tinyurl.com/jva7ron; http://www.gilead.com/
https://tinyurl.com/ya7oeqms"

My VCEL Pitch: "http://investors.vcel.com/static-files/9911d2ec-080e-44e7-b6d5-bba1bfed8655"

My CDMO Pitch: "http://ih.advfn.com/p.php?pid=nmona&article=55726349
http://www.peregrineinc.com/images/stories/pdfs/2013_asco_breast.pdf
2016 ASM:http://tinyurl.com/z3nv3g9
AACR 2017: http://tinyurl.com/jxfm3hb
Exosome studies; Cancer diagnostic:https://tinyurl.com/yd3n5kbk
https://tinyurl.com/ya6tgxxa"

My WFM Pitch: "We have shopped for groceries at WFM for many years. We like its quality--if you like the company's product chances are you should buy its stock. Our split-adjusted basis is $17.37. AMZN purchased WFM for $42/share in 2017."

My ARIA Pitch: "Our basis is $2.29. I am confident of share price increase predicated on upcoming catalysts at FDA, recent financing and potential buy-out. Doubled holdings on 11/07/2013. Takeda agrees to acquire ARIA: $24/share
http://tinyurl.com/jrahcmc"

My Pitch: "http://tinyurl.com/gsvoj2l
http://tinyurl.com/luke478
http://tinyurl.com/n6zc5dd
http://tinyurl.com/mvk6ul4
http://www.futuremedicine.com/doi/pdf/10.2217/rme.14.89
http://stemcellassays.com/2015/03/products-pipeline-ocata-rpe/
http://tinyurl.com/onobvuq
Astellas TO successful @ $8.50, 01/20"

My SBUX Pitch: "Our split-adjusted bases:$2.19 and $2.984.I look forward to its continued global expansion, particularly in Europe, China, Vietnam, Italy and India. Founder Howard Schultz has led turn-around in U.S. Recent earnings and developments: https://news.starbucks.com/"

My CPRX Pitch: "http://tinyurl.com/o6guvhe"

My AMLN Pitch: "One of leading T2Diabetes and obesity-focused companies. Underwent takeover examination by >5 companies [AZN,NVS,BMY,SNY,MRK], reported bids >$25/share. BMY/AZN TO @$31/share expired 08/07. I accumulated in many tranches since 1995; basis for 85% of holdings is $6.60/share. Shares now gone @$31."

My SGEN Pitch: "http://finance.yahoo.com/news/seattle-genetics-highlights-updated-survival-110000422.html

Our basis is $6.30."